Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cel Sci Corp (CVM)  
$1.27 0.00 (0.00%) as of 4:30 Tue 5/28


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 38,620,000
Market Cap: 49.05(M)
Last Volume: 2,036,333 Avg Vol: 2,030,754
52 Week Range: $1.07 - $3.08
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CEL-SCI is a clinical-stage biotechnology company focused on research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. Co. is focused on the development of the following product candidates and technologies: Multikine® (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for the potential treatment of certain head and neck cancers; and Ligand Epitope Antigen Presentation System technology, with CEL-4000 as a product candidate under development for the potential treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 58,000 58,000 58,000 58,000
Total Buy Value $80,620 $80,620 $80,620 $80,620
Total People Bought 3 3 3 3
Total Buy Transactions 3 3 3 3
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 599
  Page 10 of 24  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kersten Geert R Chief Executive Officer   •       •      –    2014-08-06 4 A $1.09 $6,322,000 D/D 5,800,000 6,537,310     -
   Zimmerman Daniel H Senior Vice President   •       –      –    2014-06-30 4 A $1.24 $3,349 D/D 2,701 55,587     -
   Talor Eyal Chief Scientific Officer   •       –      –    2014-06-30 4 A $1.24 $2,399 D/D 1,935 61,377     -
   Prichep Patricia B Senior Vice President   •       –      –    2014-06-30 4 A $1.24 $3,597 D/D 2,901 108,826     -
   Kersten Geert R Chief Executive Officer   •       •      –    2014-06-30 4 A $1.24 $3,824 D/D 3,084 737,310     -
   Prichep Patricia B Senior Vice President   •       –      –    2014-03-31 4 A $1.52 $3,561 D/D 2,343 105,925     -
   Talor Eyal Chief Scientific Officer   •       –      –    2014-03-31 4 A $1.52 $2,399 D/D 1,578 59,442     -
   Zimmerman Daniel H Senior Vice President   •       –      –    2014-03-31 4 A $1.52 $3,318 D/D 2,183 52,886     -
   Kersten Geert R Chief Executive Officer   •       •      –    2014-03-31 4 A $1.52 $3,824 D/D 2,516 734,226     -
   Zimmerman Daniel H Senior Vice President   •       –      –    2013-12-31 4 A $0.59 $3,255 D/D 5,517 50,703     -
   Talor Eyal Chief Scientific Officer   •       –      –    2013-12-31 4 A $0.59 $2,400 D/D 4,067 57,864     -
   Prichep Patricia B Senior Vice President   •       –      –    2013-12-31 4 A $0.59 $3,489 D/D 5,914 103,582     -
   Kersten Geert R Chief Executive   •       •      –    2013-12-31 4 A $0.59 $3,825 D/D 6,483 731,710     -
   Kersten Geert R CEO   •       •      –    2013-12-30 4 B $0.60 $180,000 D/D 300,000 725,227 2.81     -
   Kersten Geert R Chief Executive   •       •      –    2013-10-09 4 B $0.79 $6,632 D/D 8,400 425,227 2.81     -
   Zimmerman Daniel H Senior Vice President   •       –      –    2013-09-30 4 A $1.70 $3,254 D/D 1,914 45,186     -
   Prichep Patricia B Senior Vice President   •       –      –    2013-09-30 4 A $1.70 $3,488 D/D 2,052 97,668     -
   Talor Eyal Chief Scientific Officer   •       –      –    2013-09-30 4 A $1.70 $2,399 D/D 1,411 53,797     -
   Kersten Geert R Chief Executive   •       •      –    2013-09-30 4 A $1.70 $3,825 D/D 2,250 416,827     -
   Prichep Patricia B Senior Vice President   •       –      –    2013-06-28 4 A $0.21 $3,490 D/D 16,617 956,160     -
   Talor Eyal Chief Scientific Officer   •       –      –    2013-06-28 4 A $0.21 $2,400 D/D 11,428 523,859     -
   Zimmerman Daniel H Senior Vice President   •       –      –    2013-06-28 4 A $0.21 $3,255 D/D 15,502 432,719     -
   Kersten Geert R Chief Executive Officer   •       •      –    2013-06-28 4 A $0.21 $3,825 D/D 18,214 4,145,771     -
   Young Peter R Director   –       •      –    2013-06-19 4 B $0.24 $6,113 D/D 25,000 297,758 2.39     -
   Kersten Geert R Chief Executive   •       •      –    2013-06-14 4 B $0.24 $34,829 D/D 145,120 4,127,557 2.81     -
  599 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 24
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us